Hospital Consumables Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Hospital Consumables Market Trends and Insights

Rising Surgical and Minimally Invasive Procedure Volumes

Surgical volumes continued to recover in 2026, while minimally invasive and robotic procedures remained among the faster-growing procedure categories. Each procedure required sterile drapes, gowns, cannulae, irrigation products, and disposable instruments, increasing the clinical use of hospital consumables. In U.S. ambulatory settings, total knee arthroplasty volume grew by 27.6% in 2024, while total hip arthroplasty volume grew by 28.7%. England set a target of 500,000 robotic surgeries annually by 2035, supporting future demand for robotic-compatible single-use products in European acute care settings. The hospital consumables market benefits when suppliers align portfolios with orthopedics, urology, laparoscopic surgery, and other high-growth procedure areas.

Intensifying Healthcare-Associated Infection Prevention Requirements

Healthcare-associated infections remain a major concern for hospitals and public health systems. The World Health Organization reported that 7 in every 100 patients in high-income countries acquired at least 1 healthcare-associated infection during hospitalization, compared with 15 in every 100 patients in lower-middle-income settings. The Centers for Disease Control and Prevention reported 518,000 healthcare-associated infections in U.S. hospitals during 2023, with 61% of reported infections not linked to a specific medical device or procedure.^{[1]Centers for Disease Control and Prevention, “New CDC Data Shows Decline in Healthcare-Associated Infections,” Centers for Disease Control and Prevention, cdc.gov.} BD received FDA 510(k) clearance for Surgiphor™ 1000mL in March 2026, strengthening the role of infection-reduction features in procurement decisions across wound care, vascular access, and surgical applications.

Aging Populations and Chronic-Disease Treatment Intensity

Aging populations and the rising chronic disease burden create recurring demand for hospital consumables across acute and outpatient care settings. Diabetes treatment requires insulin syringes, glucometer strips, and intravenous access supplies, while kidney disease treatment depends on dialysis tubing, catheters, and blood circuit materials. Oncology care also requires frequent use of intravenous kits, protective equipment, procedure trays, and infusion-related products. Disease-specific bundles, including diabetes care kits and oncology administration packs, help suppliers address recurring clinical requirements and build a stable replenishment base.

Hospital Capacity Expansion and ICU Penetration in Emerging Markets

New hospital construction creates first-fill purchasing demand that differs from routine replacement demand in mature markets. New facilities require initial stocks of syringes, intravenous kits, catheters, wound care products, and infection-control supplies before patient services begin. Critical care units use high volumes of central venous catheters, arterial lines, ventilator circuits, urinary catheters, infusion sets, and monitoring products. The hospital consumables market can benefit from this activity across Asia-Pacific, the Middle East and Africa, and South America, where healthcare infrastructure investment is expanding.

GPO and Centralized-Tender Price Compression

Group purchasing organizations are embedded in the procurement cycle of 97% of US hospitals. Large purchasing organizations use their scale to negotiate lower prices and secure preferred supplier arrangements across hospital networks. The Healthcare Group Purchasing Industry Initiative reported that its members managed more than USD 100 billion in annual purchasing activity while addressing tariff pressure and provider cost constraints. Manufacturers may need to accept lower unit prices to retain contracts, especially in limited-differentiation products such as basic syringes, gloves, gauze, and standard intravenous supplies. This pressure may also push smaller suppliers to exit commodity categories or partner with distributors that support private-label programs.

Ethylene-Oxide Sterilization Capacity and Emissions Constraints

Ethylene oxide sterilizes nearly 50% of medical devices used in the United States, representing almost 20 billion devices each year. The process is critical for catheters, intravenous kits, procedure trays, and surgical drapes that cannot withstand steam or radiation sterilization. The 2024 National Emission Standards for Hazardous Air Pollutants rule created supply concerns and led to a presidential exemption process in January 2025. The Environmental Protection Agency proposed reconsideration of the 2024 rule in March 2026 while maintaining plans for new emissions standards at larger facilities. Uncertainty over future requirements can delay sterilization capacity investments and affect supply planning for manufacturers that rely on third-party sterilization providers. Medical waste rules, polymer disposal costs, product recalls, and quality system obligations add further cost and operational pressure across the hospital consumables market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Non-Woven Products Lead While Disposable Syringes Grow Fastest

Non-woven disposable products held 24.55% of the hospital consumables market size in 2025, making them the largest product category. Their leadership reflected broad use in surgical drapes, gowns, face masks, sterile wraps, caps, wound management products, and incontinence care across multiple care settings. Polypropylene spunbond remained widely used due to its cost efficiency and suitability for high-volume manufacturing. European waste regulations and extended producer responsibility frameworks increased attention on biodegradable and bio-based alternatives.

Disposable syringes are forecast to grow at a CAGR of 7.15% between 2026 and 2031. Hospitals and public health programs increasingly used safety-engineered formats, including retractable, auto-disable, and passive-mechanism syringes, supported by occupational safety and sharps injury prevention requirements in North America and Europe. Higher use of GLP-1 receptor agonists for type 2 diabetes and obesity also expanded demand for prefilled and self-injection products. Catheters, intravenous kits, intravenous solutions, guidewires, cannulae, and procedure trays supported recurring revenue through continuous purchasing and bundled contracts.

By Application Area: Operating Rooms Lead While Intensive Care Expands

General surgery and operating rooms accounted for 33.56% of the hospital consumables market share in 2025. Operating rooms used a broad range of consumables in each surgical case, including drapes, gowns, gloves, sutures, blade holders, irrigation systems, specimen containers, and sterile packaging. Complex procedures can require more than USD 300 in consumables per case. The World Health Organization estimated that more than 313 million surgical procedures are performed globally each year, supporting recurring demand for surgical consumables.

Intensive care and critical care are forecast to grow at a CAGR of 5.80% between 2026 and 2031. Intensive care units required continuous supplies of central venous catheters, arterial lines, ventilator circuits, urinary catheters, infusion sets, and glucose monitoring products, driven by expanding critical care capacity in developing healthcare systems. BD launched the CentroVena One™ Insertion System in April 2026 for central line placement in acute care settings. Oncology, chemotherapy administration, urology, nephrology, and wound care also supported demand through specialized products and differentiated clinical requirements.

By End User: Hospitals Remain the Core Customer Base While ASCs Gain Momentum

Hospitals represented 56.77% of end-user revenue in 2025. They remained the primary setting for major surgery, intensive care, emergency treatment, inpatient management, and other high-acuity care episodes. Large hospital systems centralized purchasing and used vendor-managed inventory arrangements to control supply levels across multiple facilities. These systems favored suppliers that could support consistent product specifications and delivery schedules across several locations.

Ambulatory surgical centers are forecast to grow at a CAGR of 6.45% from 2026 to 2031. U.S. ambulatory surgical center procedure volumes per Medicare beneficiary increased 3.5% in 2024. The 2026 phase-out of the inpatient-only list added 285 new HCPCS codes to the ambulatory surgical center Covered Procedure List, including total hip arthroplasty revisions and complex spinal procedures. Medical supply product sales to ambulatory surgical centers through distribution reached nearly USD 2.7 billion in 2025, up 4% from the previous year, while surgical instrument sets and sutures grew 9.2% and 8.6%, respectively.

By Distribution Channel: Direct Contracts Lead While Prime Vendors Gain Ground

Direct manufacturer contracts held 39.88% of revenue in 2025. Large integrated delivery networks used these contracts to secure volume commitments, pricing visibility, and standardized supplies across facilities. This model was especially common for intravenous solutions, procedure trays, non-woven products, and other high-spend categories. Group purchasing organizations remained involved in negotiations, although hospitals often managed preferred supplier relationships directly.

Medical distributors and prime vendors are forecast to grow at a CAGR of 7.56% from 2026 to 2031. The prime vendor model allowed a single distributor to manage sourcing, logistics, replenishment, and product availability for a broad range of medical and surgical products. Medline signed its first prime vendor agreement outside the United States with Mohawk Medbuy in May 2026 to support hospitals in Southwestern Ontario, including daily distribution from Medline’s Guelph, Ontario, facility. Digital procurement also gained traction among specialty clinics, diagnostic laboratories, and home healthcare providers by improving ordering visibility and inventory planning.

Geography Analysis

North America held 40.86% of the hospital consumables market size in 2025. High consumable use per procedure, established safety-device requirements, and a large ambulatory surgical center base supported the region’s position. The United States accounted for most regional revenue due to its high volume of complex procedures and detailed product quality requirements. FDA clearance pathways and Joint Commission accreditation standards encouraged the use of products meeting established safety and performance specifications, while Canada moved toward centralized procurement through Medline’s May 2026 prime vendor agreement with Mohawk Medbuy. Mexico remained an underpenetrated opportunity as public and private hospital networks continued to expand.

Europe remained the second-largest regional area in the hospital consumables market. Germany, France, the United Kingdom, and Italy formed the core of regional demand. The European Union Medical Device Regulation raised clinical evidence and post-market surveillance requirements, increasing compliance demands for smaller manufacturers and favoring suppliers with established regulatory capabilities and local manufacturing capacity. Convatec completed an expansion of more than GBP 24 million at its United Kingdom advanced wound care manufacturing site during 2026 and also announced research and development investment of more than GBP 500 million, including a Manchester hub planned from 2028.

Asia-Pacific is forecast to grow at a CAGR of 6.88% from 2026 to 2031, making it the fastest-growing regional area. Hospital construction, a growing middle-income population, increasing chronic disease treatment, and broader access to surgery and critical care support demand. India is adding specialty and higher-acuity capacity, increasing demand for operating room, infusion, wound care, and intensive care products, while China remains a major destination due to its extensive healthcare infrastructure and local manufacturing base.